Solesence Inc. (SLSN) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Public company logo of Solesence Beauty (SLSN)

The Solesence Inc (SLSN) share price visualized below in the context of EV/EBITDA stands at 98.39. The company possesses significant pricing power over its unique UV components, allowing it to easily raise prices for the premium segment. The business generates revenue through the sale of licenses for innovative formulas, thereby avoiding plant maintenance costs. However, reliance on a narrow circle of distributors and raw material price volatility create certain risks.

Solesence Beauty - SLSN Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/12/2026)
Original product of Solesence

Supply chain disruptions and sanction-driven raw material price hikes for Solesence Inc (SLSN) directly impact operating profitability. These costs adjust EBITDA, altering the final value of the formula. The metric compares the total enterprise value, including net debt and market capitalization, with earnings before depreciation and amortization to determine the asset's fair value. By analyzing the EV/EBITDA chart, an investor can promptly identify a market overvaluation of the stock.

Who Solesence Inc competes with

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Krystal Corp KRYS|Total Company Value to Operating Income Before Depreciation Ratio Apogee Corp (APGE)|ARQT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VCEL - EV/EBITDA Multiple|ORKA: EV/EBITDA Multiple|SMTI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DBV Tech|Enterprise Value to Operating Income Before Depreciation DERM (Journey Medical Corp.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Forte Biosciences, Inc. (FBRX)|Total Company Value to Operating Income Before Depreciation Ratio empro.my|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sol-Gel Technologies Ltd. SLGL|AXIL Brands Inc (AXIL) - Company Value to EBITDA|MDCX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VRCA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HOTH: EV/EBITDA Multiple|Company Value to EBITDA Biofrontera (BFRI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VYNE Therapeutics, Inc.|Sonoma Pharma (SNOA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QNRX|AZTR - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dermata Therapeutics DRMA|ELAB: Enterprise Value to Operating Income Before Depreciation|Revance Therapeutics, Inc. - EV/EBITDA Multiple